The Scientist

» drug development, immunology and culture

Most Recent

Malaria parasites transmitted via mosquitoes elicit a more effective immune response and cause less severe infection than those directly injected into red blood cells.

0 Comments

image: Modified Toxin to Treat Obesity?

Modified Toxin to Treat Obesity?

By | May 29, 2013

Researchers show that a synthetic peptide derived from a sea anemone toxin has potent weight-regulating effects in a mouse model of obesity.  

0 Comments

image: Behavior Brief

Behavior Brief

By | May 23, 2013

A round-up of recent discoveries in behavior research

1 Comment

image: Macrophages Drive Regeneration

Macrophages Drive Regeneration

By | May 22, 2013

The activity of one type of immune cell helps regrow the limbs of amputated salamanders.

3 Comments

image: Vitamin C Slays TB Bacteria

Vitamin C Slays TB Bacteria

By | May 21, 2013

The essential nutrient can kill drug-resistant Mycobacterium tuberculosis by producing oxidative radicals that damage DNA.

1 Comment

image: Nano-vehicles for Cancer Drugs

Nano-vehicles for Cancer Drugs

By | May 20, 2013

Experimental cancer therapeutics delivered to tumors via nanoparticles could provide a safer and more effective therapy than conventional chemotherapy.

1 Comment

image: New Guardians Against Diabetes?

New Guardians Against Diabetes?

By | May 20, 2013

A new class of immune cell could protect against type 1 diabetes by suppressing other immune cells.

1 Comment

image: Opinion: Ethics Training in Science

Opinion: Ethics Training in Science

By | May 14, 2013

The NIH has required researchers to receive instruction about responsible conduct for more than 20 years, but misconduct is still on the rise.

9 Comments

image: Opinion: Remediating Misconduct

Opinion: Remediating Misconduct

By | May 14, 2013

Should institutions invest in changing the behavior of scientists found guilty of violating research rules and ethics?

3 Comments

image: Release of Drug Data Blocked

Release of Drug Data Blocked

By | May 2, 2013

A court ruling that stops the European Medicines Agency from releasing data from two US companies calls into question the agency’s push for transparency.

0 Comments

Popular Now

  1. Opinion: Why I Published in a Predatory Journal
    News & Opinion Opinion: Why I Published in a Predatory Journal

    My “colleagues” and I at the fictitious Arthur Vandelay Urological Research Institute were surprised to find our bogus “uromycitisis” case report swiftly accepted, with only minor revisions requested.

  2. Consilience, Episode 3: Cancer, Obscured
  3. A History of Screening for Natural Products to Fight Cancer
  4. March for Science: Dispatches from Washington, DC
AAAS